This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Iadecola C. Dangerous Leaks: Blood–brain barrier woes in the aging hippocampus. Neuron 2015, 85: 231–233.
Yang Q, Chen K, Zhang H, Zhang W, Gong C, Zhang Q, et al. Correlations between single nucleotide polymorphisms, cognitive dysfunction, and postmortem brain pathology in Alzheimer’s disease among Han Chinese. Neurosci Bull 2019, 35: 193–204.
Montagne A, Nation DA, Sagare AP, Barisano G, Sweeney MD, Chakhoyan A, et al. APOE4 leads to blood–brain barrier dysfunction predicting cognitive decline. Nature 2020, 581: 71–76.
Montagne A, Zhao Z, Zlokovic BV. Alzheimer’s disease: A matter of blood–brain barrier dysfunction? J Exp Med 2017, 214: 3151–3169.
Nation DA, Sweeney MD, Montagne A, Sagare AP, D’Orazio LM, Pachicano M, et al. Blood–brain barrier breakdown is an early biomarker of human cognitive dysfunction. Nat Med 2019, 25: 270–276.
Santos G, Magno L, Romano-Silva MA, Mintz A, Birbrair A. Pericyte plasticity in the brain. Neurosci Bull 2019, 35: 551–560.
Bell RD, Winkler EA, Singh I, Sagare AP, Deane R, Wu Z, et al. Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature 2012, 485: 512–516.
Halliday MR, Rege SV, Ma Q, Zhao Z, Miller CA, Winkler EA, et al. Accelerated pericyte degeneration and blood–brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer’s disease. J Cereb Blood Flow Metab 2016, 36: 216–227.
Miners JS, Schulz I, Love S. Differing associations between Abeta accumulation, hypoperfusion, blood–brain barrier dysfunction and loss of PDGFRB pericyte marker in the precuneus and parietal white matter in Alzheimer’s disease. J Cereb Blood Flow Metab 2018, 38: 103–115.
Montagne A, Barnes SR, Sweeney MD, Halliday MR, Sagare AP, Zhao Z, et al. Blood–brain barrier breakdown in the aging human hippocampus. Neuron 2015, 85: 296–302.
Fan D, Wang Y. Early intervention in Alzheimer’s disease: How early is early enough? Neurosci Bull 2020, 36: 195–197.
Sun B, Li W, Zhu C, Jin W, Zeng F, Liu Y, et al. Clinical research on Alzheimer’s disease: Progress and perspectives. Neurosci Bull 2018, 34: 1111–1118.
This research highlight was supported by the National Key Projects for Research and Development Program of China (2016YFC1305800 and 2016YFC1305802); the National Natural Science Foundation of China (81671256 and 81871069); the Key Project for Research and Development Program of Jiangsu Province (BE2018741), and the Nanjing International Joint Research and Development Project (201715013).
Conflict of interest
All authors declare no competing interest.
About this article
Cite this article
Zhang, Q., Xie, C. Apolipoprotein E Drives Early Blood–Brain Barrier Damage in Alzheimer’s Disease. Neurosci. Bull. (2020). https://doi.org/10.1007/s12264-020-00596-2